Also, HCC tumor samples with higher PRMT3 expression had clinicopathologic features associated with more aggressive disease, such as larger tumor sizes, advanced tumor stages, and higher AFP levels (Supplementary Fig. 3D–G). Here, PRMT3 is linked to hepatocellular carcinoma.